NCT02557932View on ClinicalTrials.gov

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

September 28, 2019

Conditions
Helicobacter Pylori InfectionFamily History of Stomach Cancer
Interventions
DRUG

Standard triple therapy

Lansoprazole 30mg, 2 times a day + Clarithromycin 500mg, 2 times a day + Amoxicillin 1000mg, 2 times a day for 7 days

DRUG

Bismuth quadruple therapy

Lansoprazole 30mg, 2 times a day + Bismuth 300mg, 4 times a day + Tetracycline 500mg, 4 times a day + Metronidazole 500mg, 3 times a day for 10 days

Trial Locations (1)

10408

National Cancer Center, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT02557932 - Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication | Biotech Hunter | Biotech Hunter